Research & Development Center, Royal Canin SAS, 650 avenue de la Petite Camargue, Aimargues 30470, USA

Biography

Dr. Yann Quéau is a veterinary nutritionist specializing in small animal clinical nutrition and nephrology. He graduated from the National Veterinary School in Toulouse, France, in 2007, after completing a veterinary thesis on the effect of aging on the glomerular filtration rate in dogs. VETCO Following his graduation, Dr. Quéau completed an internship in Renal Medicine and Hemodialysis and a residency in Small Animal Clinical Nutrition at the University of California, Davis. In 2011, he became a Diplomate of the American College of Veterinary Nutrition (ACVN). VETFOCUS Dr. Quéau joined the Royal Canin global Research and Development center in France as a clinical and research nutritionist, leading the urinary and nephrology research programs. Since 2017, he has been in charge of the research team dedicated to clinical nutrition and veterinary diets. VETFOCUS His research focuses on the nutritional management of urolithiasis in dogs and cats. Notably, he co-authored the article "Nutritional Management of Urolithiasis" published in Veterinary Clinics: Small Animal Practice in 2019. VETSMALL Dr. Quéau has also contributed to studies on the adequacy of essential nutrient intake in obese dogs undergoing energy restriction for weight loss. One such study, titled "Assessing the adequacy of essential nutrient intake in obese dogs undergoing energy restriction for weight loss: a cohort study," was published in BMC Veterinary Research in 2015. BMC VETERINARY RESEARCH In 2023, Dr. Quéau joined BluePearl as Divisional Vice President of Medicine-East.

Publications

• Research Article   
  Modification of a Targeted Metabolomics Method Using Hydrophilic Interaction Liquid Chromatography-High Resolution Mass Spectrometry to Measure Nine Purines in Commercial Dog Foods
  Author(s): Chie Saito Ishii*, Karen C Scott, Carolina Abrahan, Joy G. Cagmat, Taylor A. Harmon, Yann Queau, Vincent Biourge, Timothy J. Garrett and Richard C Hill
  
  Urate is the third most common component of canine uroliths. Dogs with a genetic mutation or hepatic dysfunction are prone to forming urate uroliths because they excrete more poorly soluble urate as the end product of purine metabolism. Dietary purine restriction has been reported to reduce urinary urate concentrations in dogs, but the amount and types of purine in commercial diets have not been well documented. A previous targeted metabolomics method was modified to measure eleven purine metabolites in commercial dog foods. The method utilized hydrophilic interaction liquid chromatography-high-resolution tandem mass spectrometry with stable isotope-labeled internal standards. The within-day and between-day coefficient of variation of each purine metabolite concentration in quality control dog food samples averaged 6% (range: 4%-13%) and 15% (range: 11%-19%), respectively. Recoveries .. View More»
  DOI: 10.35248/2157-7064.23.14.539

  Abstract HTML PDF

Other relevant publications from this author

• Nutritional Management of Urolithiasis

  Assessing the adequacy of essential nutrient intake in obese dogs undergoing energy restriction for weight loss: a cohort study

  Obese dogs with and without obesity-related metabolic dysfunction – a proteomic approach

  Increasing dietary sodium chloride promotes urine dilution and decreases struvite and calcium oxalate relative supersaturation in healthy dogs and cats